Anatara Lifesciences Ltd (ANR.AX) Stock Overview
Explore Anatara Lifesciences Ltd’s financial performance, market position, analyst ratings, and future outlook.
Anatara Lifesciences Ltd (ANR.AX)
Key Financials
Key Financials
Market Cap
2.3M
P/E Ratio
-2.91
EPS (TTM)
$-0.01
ROE
-1.09%
ANR.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Anatara Lifesciences Ltd (ANR.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 68.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.91 and a market capitalization of 2.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.